Article Sidebar

PDF (Tiếng Việt)
Published: 2023-01-30
Abstract Views: 262
Views PDF (Tiếng Việt): 268
DOI: https://doi.org/10.52852/tcncyh.v160i12V2.1182
Issue
Vol. 160 No. 12V2 (2022)
Section
Các bài báo
How to Cite
Hương, N. T. T. ., Sơn, T. M. ., Dũng, V. C. ., & Khánh, T. V. . (2023). 38. Mutation detection of COL1A1 gene in a patient with osteogenesis imperfecta using next - generation sequencing: A case report. Journal of Medical Research, 160(12V2), 325-329. https://doi.org/10.52852/tcncyh.v160i12V2.1182

38. Mutation detection of COL1A1 gene in a patient with osteogenesis imperfecta using next - generation sequencing: A case report

Nguyen Thi Thu Huong, Tong Minh Son, Vu Chi Dung, Tran Van Khanh

Main Article Content

Abstract

Osteogenesis imperfecta (OI) is a heritable, connective tissue disorder characterized by increased bone fragility, low bone mass, and short stature. More than 90% of cases are caused by mutations in the COL1A1 (OMIM 120150) and COL1A2 (OMIM 120060) genes, which encode collagen type 1 alpha chains. We presented a case of a 10-year-old male with OI type III who was treated at Hanoi National Children's Hospital diagnosed. Gene sequencing was performed for the patient and parents using the next generation sequencing technology. A dominant heterozygous de novo mutation, pathogenic, at exon 8 of the COL1A1 ( c.608G>T, p.Gly203Val) was identified for the patient. Gene testing plays an important role in diagnosis, developing individualized treatment, and genetic counseling.

Article Details

Keywords

osteogenesis imperfecta, COL1A1 mutation, next-generation sequencing

References

1. Basel D, RD. Steiner. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. Genetics in medicine. 2009;11(6):p.375-385.
2. Sillence D, A Senn, D Danks. Genetic heterogeneity in osteogenesis imperfecta. Journal of medical genetics. 1979;16(2):p.101-116.
3. Van Dijk F, et al. Classification of osteogenesis imperfecta revisited. European journal of medical genetics. 2010;53(1):p.1-5.
4. Forlino A, et al. New perspectives on osteogenesis imperfecta. Nature Reviews Endocrinology. 2011;7(9):p.540-557.
5. Van Dijk F, D. Sillence. Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. American journal of medical genetics Part A. 2014;164(6):p.1470-1481.
6. Cheung MS, FH. Glorieux. Osteogenesis imperfecta: update on presentation and management. Reviews in Endocrine and Metabolic Disorders. 2008;9(2):p.153-160.
7. Shapiro JR. Osteogenesis imperfecta: A translational approach to brittle bone disease. Academic Press. 2013
8. Forlino A, JC Marini. Osteogenesis imperfecta. The Lancet. 2016;387(10028): p.1657-1671.
9. Prockop DJ, et al. Type I procollagen: The gene - protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue. American journal of medical genetics. 1989;34(1):p.60-67.
10. Trancozo M, et al. Osteogenesis imperfecta in Brazilian patients. Genetics and molecular biology. 2019;42:p.344-350.
11. Gardner A, et al. The use of magnetically controlled growing rods in paediatric Osteogenesis Imperfecta with early onset, progressive scoliosis. Journal of Surgical Case Reports. 2018;2018(3):p.rjy043.
12. Gioia R, et al. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: A new target for osteogenesis imperfecta pharmacological therapy. Stem Cells. 2012;30(7):p.1465-1476.
13. Zhang H, et al. Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta. Molecular medicine reports. 2016;14(5):p.4918-4926.